TRIPI, Silvio
 Distribuzione geografica
Continente #
NA - Nord America 1.180
EU - Europa 588
AS - Asia 470
SA - Sud America 66
AF - Africa 17
OC - Oceania 2
Totale 2.323
Nazione #
US - Stati Uniti d'America 1.170
CN - Cina 176
IT - Italia 171
SG - Singapore 162
UA - Ucraina 77
FI - Finlandia 71
BR - Brasile 52
RU - Federazione Russa 49
DE - Germania 44
HK - Hong Kong 44
IE - Irlanda 42
SE - Svezia 27
GB - Regno Unito 24
FR - Francia 23
PL - Polonia 23
VN - Vietnam 23
BE - Belgio 14
IN - India 10
BD - Bangladesh 8
CI - Costa d'Avorio 8
TR - Turchia 8
IR - Iran 7
CA - Canada 6
AT - Austria 5
ES - Italia 5
IQ - Iraq 5
KR - Corea 5
NL - Olanda 5
AM - Armenia 4
AR - Argentina 4
MA - Marocco 4
RO - Romania 4
VE - Venezuela 4
CL - Cile 3
JP - Giappone 3
MX - Messico 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
EC - Ecuador 2
EG - Egitto 2
LB - Libano 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
DZ - Algeria 1
HN - Honduras 1
ID - Indonesia 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PY - Paraguay 1
QA - Qatar 1
SN - Senegal 1
ZA - Sudafrica 1
Totale 2.323
Città #
Ashburn 161
Chandler 133
Fairfield 98
Singapore 86
Houston 57
Wilmington 55
Woodbridge 52
Ann Arbor 50
Des Moines 50
Hong Kong 43
Dublin 42
Jacksonville 42
Seattle 41
Cambridge 37
Beijing 32
Medford 26
New York 23
Dearborn 20
Nanjing 20
Boardman 19
The Dalles 18
Moscow 17
Princeton 17
Zgierz 17
Palermo 15
Altamura 14
Brussels 14
Rome 13
Buffalo 12
Jinan 12
Los Angeles 12
Milan 11
San Diego 11
Tulsa 10
Changsha 9
Ho Chi Minh City 9
Nanchang 9
Abidjan 8
Lawrence 8
Shenyang 8
Tianjin 8
Dallas 7
Hebei 7
Hefei 6
Izmir 6
Tehran 6
Chicago 5
Munich 5
Venice 5
Frankfurt am Main 4
Genoa 4
Hangzhou 4
Hanoi 4
Nuremberg 4
Seongnam 4
São Paulo 4
Warsaw 4
Yerevan 4
Baghdad 3
Bauru 3
Haiphong 3
Jiaxing 3
Kunming 3
Lanzhou 3
London 3
Ludwigshafen am Rhein 3
Ningbo 3
San Paolo di Civitate 3
Sant'Antimo 3
Santa Clara 3
Shenzhen 3
Taizhou 3
Tashkent 3
Tokyo 3
Zhengzhou 3
Bastia umbra 2
Boston 2
Brooklyn 2
Cagliari 2
Chennai 2
Duncan 2
Enna 2
Haikou 2
Lages 2
Modena 2
Naples 2
Norwalk 2
Parma 2
Partinico 2
Pomigliano d'Arco 2
Quảng Ngãi 2
Redwood City 2
Riyadh 2
Roubaix 2
Stockholm 2
Tappahannock 2
Toronto 2
Vazzola 2
Vienna 2
Abinsk 1
Totale 1.522
Nome #
Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia. 191
Perihepatic limph nodes and anti-viral response in chronic HCV-associated hepatitis 165
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 165
Percutaneous liver biopsy: A safe outpatient procedure? 162
Ultrasound detection of abdominal lymph nodes in chronic liver diseases. A retrospective analysis 161
Leucocyte interferon-alpha for patients with chronic hepatitis C intolerant to other alpha-interferons 155
Affidabilità del bright liver nella steatosi epatica in soggetti con ipertransaminasemia criptogenetica e con epatopatia da virus C 146
Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma 142
Studio sulla frequenza dei genotipi virali e loro risposta terapeutica su un gruppo di soggetti ex drug dipendents con epatite cronica HCV-correlata. 136
Relazione tra linfoadenopatia del legamento epatoduodenale e risposta alla terapia anti-virale in pazienti con epatite cronica HCV-correlata 135
Retreatment of interferon plus ribavirin unresponsive patients with chronic hepatitis C with peginterferon alfa 2a plus mycofenolatemofetile or peginterferon alfa 2 a plus ribavirin 125
Himpact of liver steatosis on the antiviral response in the hepatitis C virus –associated chronic hepatitis. 117
The treatment of chronic hepatitis C: role of ICAM-1 and response to interferon 111
EPATOPATIE NEI MIGRANTI 110
Early reduction of serum HBsAg levels in HBeAg negative chronic hepatitis B patients achieving sustained virological response after peginterferon alfa 2a +/- ribavirin treatment . 104
Safety and efficacy of Peginterferon (PEG-IFN) alpha 2 a(40 Kda) plus mycofenolatemofetile (MMF) and Peginterferon alpha 2 a plus Ribavirin (RBV) in unresponsive patients with chronic C hepatitis (CHC). 97
Randomised trial of two different daily doses of interferon-α versus classical therapy in treatment-naïve patients with chronic hepatitis C 87
null 74
Totale 2.383
Categoria #
all - tutte 8.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.290


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021108 0 0 0 0 0 7 16 8 30 11 17 19
2021/2022181 6 45 2 9 3 1 5 13 21 27 10 39
2022/2023361 23 58 2 44 37 70 35 33 41 3 12 3
2023/2024186 8 28 5 37 12 30 3 5 3 7 19 29
2024/2025322 13 10 8 19 16 17 17 18 39 31 58 76
2025/2026420 95 32 56 68 109 60 0 0 0 0 0 0
Totale 2.383